Table 3 Univariate and multivariate survival analysis of prognostic factors in MPM patients
Characteristics | OS rate (%) | Univariate | Multivariate | ||
|---|---|---|---|---|---|
1Y | 5Y | P value | HR(95 % CI) | P value | |
Age(years) | 0.95 | 1.16(0.61-2.21) | 0.65 | ||
<70Y | 94 % | 68 % | |||
> = 70Y | 91 % | 67 % | |||
Gender | 0.15 | 1.05(0.54-2.03) | 0.89 | ||
Male | 90 % | 66 % | |||
Female | 98 % | 70 % | |||
Smoking status | 0.28 | 0.74(0.38-1.45) | 0.38 | ||
Never smoker | 95 % | 70 % | |||
Smoker | 88 % | 63 % | |||
Stage for lung cancer | <0.001 | 1.66(1.38-2.03) | <0.001 | ||
I | 93 % | 91 % | |||
II | 100 % | 79 % | |||
III | 95 % | 55 % | |||
IV | 88 % | 55 % | |||
Treatment for other cancers | 0.14 | 1.21(0.75-1.95) | 0.44 | ||
Curative | 94 % | 75 % | |||
Palliative | 92 % | 63 % | |||
Histological type | 0.16 | 1.14(0.92-1.43) | 0.24 | ||
Adenocarcinoma | 93 % | 69 % | |||
Squamous cell carcinoma | 93 % | 67 % | |||
SCLC | 88 % | 53 % | |||
Other NSCLC | 100 % | 86 % | |||
Time of occurrence | <0.001 | 0.19(0.10-0.36) | <0.001 | ||
Synchronous | 80 % | 61 % | |||
metachronous | 100 % | 71 % | |||
Order of occurrence | 0.047 | 0.85(0.49-1.47) | 0.56 | ||
LCF | 88 % | 63 % | |||
OCF | 94 % | 69 % | |||